Andere talen KALA BIO, Inc.

Aandelen

KALA

US4831192020

Beurs gesloten - Nasdaq Andere beurzen 22:30:01 23-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
6,566 ^USD	+3,73%		-3,98%	-6,20%

02/04	KALA BIO, INC. : HC Wainwright herhaalt koopadvies	ZM
29/03	KALA BIO, Inc. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	01/04
KALA BIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
KALA BIO, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/03
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	29/03
KALA BIO, Inc. announced that it expects to receive $8.599799 million in funding from Baker Bros. Advisors LP	25/03
North American Morning Briefing : Stocks Struggle After New Records	22/03
North American Morning Briefing : Inflation -2-	15/03
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference	26/02
KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference	06/02
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	19/01
KALA BIO, Inc. announced that it expects to receive $1.999824 million in funding	21/12
KALA BIO, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update	13/11
KALA BIO Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	21-09-23
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	20-09-23
KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment Conference	05-09-23
KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update	07-08-23
KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update	04-08-23
KALA BIO, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	04-08-23
Kala Pharmaceuticals : Certificate of Incorporation/Bylaws - Form 8-K	02-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen KALA BIO, Inc.

Aandelen

KALA

US4831192020

Andere talen

Filters